cagrisema phase 3 results 2025 semaglutide cagrilintide obesity drug: what the data shows Updates in Medicine | CagriSema

Blood sugar rises, and youre on the path toward diabetes

J Lab Autom

Semaglutide plateaus Weight loss plateaus are common and expected

It will also be interesting to see how the different trial designs can help us examine if the amount of weight loss can account for the extent or pattern of CV benefits, beyond their direct effects on atherosclerosis outcomes. Can I get it for my patients? In a study published in Obesity in February 2020, researchers used the Health Economics Medical Innovation Simulation, a well-established simulation model, to quantify the societal value of anti-obesity medications for American adults in 2019